Company news
ImmuPharma plc news in 2016
ImmuPharma plc's news releases, calls and decks from 2016, newest first.
Update on Lupuzor Pivotal Phase III Study
December 22, 2016
Update on Cancer Compound IPP-204106 'Nucant'
November 16, 2016
Close of Accelerated Bookbuild
October 21, 2016
Half-year Report
September 30, 2016
Update on Lupuzor's pivotal phase III study
September 14, 2016
Symposium with Lupuzors Inventor Prof. S Muller
June 8, 2016
European Patients Commence Dosing in Lupuzor
June 7, 2016
Annual Financial Report & Notice of AGM
May 4, 2016
Notice of Results
April 26, 2016
First European Site Opens - Patient Recruitment
March 9, 2016
EIS and VCT Qualifying Status and Issue of Equity
March 1, 2016
Issue of Equity
February 24, 2016
Result of GM
February 22, 2016
US patients commence dosing in phase III study
February 15, 2016
Placing and Subscription Raises £8.3 million
February 5, 2016